Center-Authored Papers

Filters: Author is Appelbaum,F. R.  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
No Keywords
Matthews DC, Appelbaum FR, Eary JF, Hui TE, Fisher DR, Martin PJ, Durack LD, Nelp WB, Press OW, Badger CC.  1991.  Radiolabeled anti-CD45 monoclonal antibodies target lymphohematopoietic tissue in the macaque.. Blood. 78(7):1864-74. Abstract
Fang M, Storer BE, Wood B, Gyurkocza B, Sandmaier BM, Appelbaum FR.  2012.  Prognostic impact of discordant results from cytogenetics and flow cytometry in patients with acute myeloid leukemia undergoing hematopoietic cell transplantation.. Cancer. 118(9):2411-2419. Abstract
Walter RB, Gooley TA, Wood BL, Milano F, Fang M, Sorror ML, Estey EH, Salter AI, Lansverk E, Chien JW et al..  2011.  Impact of pretransplantation minimal residual disease, as detected by multiparametric flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute myeloid leukemia.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(9):1190-7. Abstract
1991
Schuening FG, Kawahara K, Miller AD, To R, Goehle S, Stewart D, Mullally K, Fisher L, Graham TC, Appelbaum FR.  1991.  Retrovirus-mediated gene transduction into long-term repopulating marrow cells of dogs.. Blood. 78(10):2568-76. Abstract
1994
Kiem HP, Darovsky B, von Kalle C, Goehle S, Stewart D, Graham T, Hackman R, Appelbaum FR, Deeg HJ, Miller AD.  1994.  Retrovirus-mediated gene transduction into canine peripheral blood repopulating cells.. Blood. 83(6):1467-73. Abstract
1995
Schuening F, Miller AD, Torok-Storb B, Bensinger W, Storb R, Reynolds T, Fisher L, Buckner CD, Appelbaum FR.  1994.  Study on contribution of genetically marked peripheral blood repopulating cells to hematopoietic reconstitution after transplantation.. Human gene therapy. 5(12):1523-34.
1997
Schuening F, Longo WL, Atkinson ME, Zaboikin M, Kiem HP, Sanders J, Scott CR, Storb R, Miller AD, Reynolds T et al..  1997.  Retrovirus-mediated transfer of the cDNA for human glucocerebrosidase into peripheral blood repopulating cells of patients with Gaucher's disease.. Human gene therapy. 8(17):2143-60.
2008
Walter RB, Boyle KM, Appelbaum FR, Bernstein ID, Pagel JM.  2008.  Simultaneously targeting CD45 significantly increases cytotoxicity of the anti-CD33 immunoconjugate, gemtuzumab ozogamicin, against acute myeloid leukemia (AML) cells and improves survival of mice bearing human AML xenografts.. Blood. 111(9):4813-6. Abstract
Pullarkat V, Slovak ML, Kopecky KJ, Forman SJ, Appelbaum FR.  2008.  Impact of cytogenetics on the outcome of adult acute lymphoblastic leukemia: results of Southwest Oncology Group 9400 study.. Blood. 111(5):2563-72. Abstract
Appelbaum FR.  2008.  Incorporating hematopoietic cell transplantation (HCT) into the management of adults aged under 60 years with acute myeloid leukemia (AML).. Best practice & research. Clinical haematology. 21(1):85-92. Abstract
Pagel JM, Hedin N, Drouet L, Wood BL, Pantelias A, Lin Y, Hamlin DK, Wilbur SD, Gopal AK, Green DJ et al..  2008.  Eradication of disseminated leukemia in a syngeneic murine leukemia model using pretargeted anti-CD45 radioimmunotherapy.. Blood. 111(4):2261-8. Abstract
Scott BL, Park JY, Deeg HJ, Marr KA, Boeckh MJ, Chauncey TR, Appelbaum FR, Storb R, Storer BE.  2008.  Pretransplant neutropenia is associated with poor-risk cytogenetic features and increased infection-related mortality in patients with myelodysplastic syndromes.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 14(7):799-806. Abstract
Furlong T, Kiem H-P, Appelbaum FR, Carpenter PA, Deeg HJ, Doney K, Flowers MED, Mielcarek M, Nash RA, Storb R et al..  2008.  Sirolimus in combination with cyclosporine or tacrolimus plus methotrexate for prevention of graft-versus-host disease following hematopoietic cell transplantation from unrelated donors.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 14(5):531-7. Abstract
Appelbaum FR.  2008.  Allogeneic hematopoietic cell transplantation for acute myeloid leukemia when a matched related donor is not available.. Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program. :412-7. Abstract
Flowers MED, Storer BE, Carpenter PA, Rezvani AR, Vigorito AC, Campregher PV, Moravec C, Kiem H-P, Fero ML, Georges GE et al..  2008.  Treatment change as a predictor of outcome among patients with classic chronic graft-versus-host disease.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 14(12):1380-4. Abstract
Appelbaum FR.  2008.  What is the impact of hematopoietic cell transplantation (HCT) for older adults with acute myeloid leukemia (AML)? Best practice & research. Clinical haematology. 21(4):667-75. Abstract
Woolfrey AE, Malhotra U, Harrington RD, McNevin J, Manley TJ, Riddell SR, Coombs RW, Appelbaum FR, Corey L, Storb R.  2008.  Generation of HIV-1-specific CD8+ cell responses following allogeneic hematopoietic cell transplantation.. Blood. 112(8):3484-7. Abstract
O'Donnell MR, Appelbaum FR, Coutre SE, Damon LE, Erba HP, Foran J, Lancet J, Maness LJ, Marcucci G, Maslak PG et al..  2008.  Acute myeloid leukemia.. Journal of the National Comprehensive Cancer Network : JNCCN. 6(10):962-93.
Appelbaum FR.  2008.  Hematopoietic cell transplantation for non-Hodgkin's lymphoma: yesterday, today, and tomorrow.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(18):2927-9.
2009
Rotta M, Storer BE, Sahebi F, Shizuru JA, Bruno B, Lange T, Agura ED, McSweeney PA, Pulsipher MA, Hari P et al..  2009.  Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allografting.. Blood. 113(14):3383-91. Abstract
McCune JS, Batchelder A, Guthrie KA, Witherspoon RP, Appelbaum FR, Phillips B, Vicini P, Salinger DH, McDonald GB.  2009.  Personalized dosing of cyclophosphamide in the total body irradiation-cyclophosphamide conditioning regimen: a phase II trial in patients with hematologic malignancy.. Clinical pharmacology and therapeutics. 85(6):615-22. Abstract
Furlong T, Martin PJ, Flowers MED, Carnevale-Schianca F, Yatscoff R, Chauncey TR, Appelbaum FR, Deeg HJ, Doney K, Witherspoon RP et al..  2009.  Therapy with mycophenolate mofetil for refractory acute and chronic GVHD.. Bone marrow transplantation. 44(11):739-48. Abstract
Koreth J, Schlenk R, Kopecky KJ, Honda S, Sierra J, Djulbegovic BJ, Wadleigh M, DeAngelo DJ, Stone RM, Sakamaki H et al..  2009.  Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials.. JAMA : the journal of the American Medical Association. 301(22):2349-61. Abstract
Gutman JA, Leisenring WM, Appelbaum FR, Woolfrey AE, Delaney C.  2009.  Low relapse without excessive transplant-related mortality following myeloablative cord blood transplantation for acute leukemia in complete remission: a matched cohort analysis.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 15(9):1122-9. Abstract
Carnevale-Schianca F, Leisenring WM, Martin PJ, Furlong T, Schoch G, Anasetti C, Appelbaum FR, Carpenter PA, Deeg HJ, Kiem H-P et al..  2009.  Longitudinal assessment of morbidity and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation: retrospective analysis of a multicenter phase III study.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 15(6):749-56. Abstract